HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 51 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $121,840 | +99.9% | 156,909 | -22.7% | 0.00% | – |
| Q4 2022 | $60,954 | +38.5% | 202,978 | +131.9% | 0.00% | – |
| Q3 2022 | $44,000 | +29.4% | 87,541 | +45.8% | 0.00% | – |
| Q2 2022 | $34,000 | -54.7% | 60,054 | +3.9% | 0.00% | – |
| Q1 2022 | $75,000 | -8.5% | 57,778 | -19.8% | 0.00% | – |
| Q4 2021 | $82,000 | +39.0% | 72,027 | +87.5% | 0.00% | – |
| Q3 2021 | $59,000 | -67.9% | 38,418 | -58.7% | 0.00% | – |
| Q2 2021 | $184,000 | +283.3% | 92,919 | +256.9% | 0.00% | – |
| Q1 2021 | $48,000 | – | 26,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |